 Connie Valdez
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy | 2 | 2022 | 33 | 1.300 |
Why?
| | Students, Pharmacy | 6 | 2024 | 96 | 1.070 |
Why?
| | Education, Pharmacy | 5 | 2024 | 121 | 0.830 |
Why?
| | Pharmacy Service, Hospital | 2 | 2022 | 81 | 0.720 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2584 | 0.690 |
Why?
| | Prescription Drugs | 1 | 2022 | 111 | 0.630 |
Why?
| | Pharmacies | 1 | 2020 | 42 | 0.620 |
Why?
| | Insulin | 3 | 2024 | 2507 | 0.590 |
Why?
| | Insulin Detemir | 1 | 2016 | 8 | 0.480 |
Why?
| | Ibuprofen | 1 | 2016 | 84 | 0.470 |
Why?
| | Nonprescription Drugs | 1 | 2016 | 65 | 0.470 |
Why?
| | Insulin Lispro | 1 | 2016 | 42 | 0.470 |
Why?
| | Polypharmacy | 1 | 2016 | 93 | 0.450 |
Why?
| | Dietary Proteins | 1 | 2016 | 136 | 0.430 |
Why?
| | Caloric Restriction | 1 | 2016 | 127 | 0.430 |
Why?
| | Renal Insufficiency | 1 | 2016 | 169 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 338 | 0.390 |
Why?
| | Hypoglycemic Agents | 4 | 2024 | 1389 | 0.380 |
Why?
| | Bariatric Surgery | 1 | 2016 | 242 | 0.360 |
Why?
| | Pharmacists | 3 | 2022 | 240 | 0.340 |
Why?
| | Adipokines | 1 | 2009 | 57 | 0.290 |
Why?
| | Educational Measurement | 3 | 2016 | 326 | 0.270 |
Why?
| | Osteoporosis | 1 | 2009 | 236 | 0.240 |
Why?
| | Bone Density | 1 | 2009 | 482 | 0.230 |
Why?
| | Body Composition | 1 | 2009 | 706 | 0.220 |
Why?
| | Heptanoic Acids | 1 | 2005 | 67 | 0.220 |
Why?
| | Health Maintenance Organizations | 1 | 2005 | 105 | 0.220 |
Why?
| | Simvastatin | 1 | 2005 | 60 | 0.220 |
Why?
| | Hypolipidemic Agents | 1 | 2005 | 88 | 0.220 |
Why?
| | Hyperlipidemias | 1 | 2005 | 122 | 0.210 |
Why?
| | Self Concept | 1 | 2006 | 253 | 0.210 |
Why?
| | Pyrroles | 1 | 2005 | 218 | 0.210 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 923 | 0.170 |
Why?
| | Patient Compliance | 1 | 2005 | 589 | 0.170 |
Why?
| | United States | 5 | 2024 | 15988 | 0.150 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 266 | 0.150 |
Why?
| | Curriculum | 2 | 2024 | 1060 | 0.150 |
Why?
| | Colorado | 5 | 2024 | 4564 | 0.150 |
Why?
| | Guatemala | 1 | 2020 | 345 | 0.140 |
Why?
| | Humans | 17 | 2024 | 144957 | 0.140 |
Why?
| | Community Pharmacy Services | 2 | 2007 | 46 | 0.120 |
Why?
| | Nephrology Nursing | 1 | 2016 | 15 | 0.120 |
Why?
| | Retrospective Studies | 4 | 2024 | 17101 | 0.120 |
Why?
| | Drug Administration Routes | 1 | 2016 | 44 | 0.120 |
Why?
| | Adult | 5 | 2024 | 40506 | 0.120 |
Why?
| | Health Services for the Aged | 1 | 2016 | 70 | 0.120 |
Why?
| | Drug Interactions | 1 | 2016 | 401 | 0.110 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 170 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1495 | 0.090 |
Why?
| | Clinical Competence | 3 | 2016 | 1244 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 544 | 0.090 |
Why?
| | Schools, Pharmacy | 3 | 2024 | 47 | 0.080 |
Why?
| | Primary Health Care | 2 | 2020 | 1734 | 0.080 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 38 | 0.080 |
Why?
| | Prescriptions | 1 | 2010 | 76 | 0.080 |
Why?
| | Resistin | 1 | 2009 | 12 | 0.080 |
Why?
| | Biological Factors | 1 | 2009 | 39 | 0.070 |
Why?
| | Economics, Pharmaceutical | 1 | 2008 | 10 | 0.070 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 222 | 0.070 |
Why?
| | Obesity | 2 | 2015 | 3082 | 0.070 |
Why?
| | Critical Illness | 1 | 2015 | 892 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 276 | 0.070 |
Why?
| | Hip Joint | 1 | 2009 | 172 | 0.070 |
Why?
| | Leptin | 1 | 2009 | 245 | 0.070 |
Why?
| | Costs and Cost Analysis | 1 | 2008 | 220 | 0.070 |
Why?
| | Adiponectin | 1 | 2009 | 244 | 0.070 |
Why?
| | Lumbar Vertebrae | 1 | 2009 | 252 | 0.060 |
Why?
| | Accreditation | 1 | 2007 | 101 | 0.060 |
Why?
| | Aspirin | 1 | 2010 | 400 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2009 | 5872 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2016 | 8279 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 6053 | 0.060 |
Why?
| | Confidentiality | 1 | 2006 | 79 | 0.060 |
Why?
| | Preceptorship | 1 | 2006 | 67 | 0.060 |
Why?
| | Middle Aged | 4 | 2016 | 35928 | 0.060 |
Why?
| | Medical Audit | 1 | 2005 | 77 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1217 | 0.050 |
Why?
| | Female | 5 | 2024 | 78376 | 0.050 |
Why?
| | Pilot Projects | 1 | 2009 | 1890 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1721 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2925 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 588 | 0.040 |
Why?
| | Research Design | 1 | 2006 | 1137 | 0.040 |
Why?
| | Aged | 3 | 2010 | 25947 | 0.040 |
Why?
| | Vaccination | 1 | 2007 | 1423 | 0.030 |
Why?
| | Male | 4 | 2024 | 72406 | 0.030 |
Why?
| | Lung | 1 | 2009 | 4109 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2015 | 32 | 0.030 |
Why?
| | Information Dissemination | 1 | 2015 | 223 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3890 | 0.020 |
Why?
| | Drug Prescriptions | 1 | 2015 | 285 | 0.020 |
Why?
| | Decision Support Systems, Clinical | 1 | 2015 | 265 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 978 | 0.020 |
Why?
| | Communication | 1 | 2016 | 967 | 0.020 |
Why?
| | Medication Therapy Management | 1 | 2010 | 73 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2010 | 223 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1416 | 0.020 |
Why?
| | Animals | 1 | 2008 | 38109 | 0.010 |
Why?
| | Guideline Adherence | 1 | 2010 | 589 | 0.010 |
Why?
| | Immunization Programs | 1 | 2007 | 194 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6434 | 0.010 |
Why?
| | Adolescent | 2 | 2015 | 22453 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1358 | 0.010 |
Why?
| | Infant | 1 | 2015 | 10039 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11799 | 0.010 |
Why?
| | Child | 1 | 2015 | 22657 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 14126 | 0.010 |
Why?
|
|
Valdez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|